Loading...
新闻2021-12-04T22:09:02-08:00

分类

Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market 

11月 30th, 2021|

Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

11月 23rd, 2021|

Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency

8月 26th, 2021|

Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry.

1月 15th, 2021|

Biohaven公司发布了Rimegepant Zydis®口腔溶解片(ODT)III期临床试验积极结果:急性偏头痛的精准疗法,效果迅速、持久

12月 3rd, 2018|

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

11月 8th, 2018|

Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资,用于推进NASH和癌症药物的研发

10月 30th, 2018|

Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant Expanded Access Program For Pitolisant Is Open And Patients Are Being Enrolled

5月 21st, 2018|
返回顶部